Jovanovic, Dragana M.
Šterclová, Martina
Mogulkoc, Nesrin
Lewandowska, Katarzyna
Müller, Veronika
Hájková, Marta
Studnicka, Michael
Tekavec-Trkanjec, Jasna
Littnerová, Simona
Vašáková, Martina http://orcid.org/0000-0002-0424-9941
Zembacher, Stefan
Studnicka, Michael
Lang, David
Lamprecht, Bernd
Stoeva, Natalia
Mladinov, Suzana
Ilak, Dino
Vergles, Mirna
Tudorić, Neven
Tekavec-Trkanjec, Jasna
Vašáková, Martina
Šterclová, Martina
Jiří,
Lacina, Ladislav
Lisá, Pavlína
Bittenglová, Radka
Bartoš, Vladimír
Renata,
Lošťáková, Vladimíra
Žurková, Monika
Pšíkalová, Jana
Binková, Ilona
Doubková, Martina
Kervitzer, Jan
Snížek, Tomáš
Reiterer, Pavel
Šuldová, Hana
Plačková, Martina
Tyl, Richard
Řihák, Vladimír
Dušek, Ladislav
Hejduk, Karel
Gregor, Jakub
Májek, Ondřej
Littnerová, Simona
Svoboda, Michal
Zsiray, Miklós
Müller, Veronika
Bohács, Anikó
Szilasi, Maria
Szalai, Zsuzsanna
Balikó, Zoltán
Somfay, Attila
Lajkó, Imre
Kramer, Mordechai
Adir, Yochai
Kjaeva, Biserka Jovkovska
Jassem, Ewa
Sieminska, Alicja
Szymanowska-Narloch, Amelia
Barczyk, Adam
Sladek, Krzysztof
Kania, Aleksander
Kasper, Lukasz
Stachura, Tomasz
Jurek, Paulina
Majewski, Sebastian
Nowicka, Agata
Borucki, Lukasz
Lewandowska, Katarzyna
Sobiecka, Małgorzata
Zolnowska, Beate
Sliwinski, Pawel
Korzybski, Damian
Martusewicz-Boros, Magdalena
Wiatr, Elzbieta
Maskey-Warzęchowska, Marta
Górska, Katarzyna
Barnaś, Małgorzata
Vučinić-Mihailović, Violeta
Milenković, Branislava
Kontić, Milica
Samardžić, Natalija
Roksandić, Marina
Jovanovic, Dragana
Pejcic, Tatjana
Boravac, Desa Nastasijevic
Videnovic, Emilija
Petkovic, Tatjana Radjenovic
Djordejevic, Ivanka
Lečić, Svetlana Kašiković
Kuruc, Vesna
Eri, Živka
Panjković, Milana
Lovrenski, Aleksandra
Kukavica, Darinka
Jakić, Ana
Mojsilovic, Slavica
Hájková, Marta
Laššán, Štefan
Tóth, Štefan
Plutinský, Ján
Vyšehradský, Róbert
Matula, Bohumil
Slivka, Róbert
Jonner, Imrich
Mogulkoc, Nesrin
,
Funding for this research was provided by:
Boehringer Ingelheim
Roche
Article History
Received: 22 November 2021
Accepted: 24 April 2022
First Online: 27 May 2022
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. The study protocol and its amendments were approved by the Ethics Committee of each participating institution. Owing to the partially retrospective nature of the study, written informed consent could not be obtained from each patient due to objective reasons, e.g., following preliminary oral consent some patients may have died or been too ill to travel to a follow-up appointment to provide written consent. Nevertheless, all records in the EMPIRE registry are fully anonymised and de-identified.
: Not applicable.
: The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). This study was supported by Boehringer Ingelheim International GmbH (BI). BI had no role in the design, analysis or interpretation of the results in this study. BI was given the opportunity to review the manuscript for medical and scientific accuracy as it relates to BI substances, as well as intellectual property considerations. Writing/editorial support and formatting assistance was provided by Helen Keyworth, PhD, of Nucleus Global, which was contracted and funded by BI. DMJ reports personal fees from Boehringer Ingelheim and Roche outside the submitted work; and advisory board participation for Boehringer Ingelheim and Roche. NM reports consulting fees paid to their institution for advisory board participation or consultancy from Boehringer Ingelheim, Roche, Bayer and Novartis Turkey; speaker honoraria paid to their institution from Boehringer Ingelheim, Roche and Nobel; and support for congress participation from Roche, Actelion and Boehringer Ingelheim. KL reports grants, consulting fees, honoraria, support for congress participation and personal fees from Roche and Boehringer Ingelheim; and is the vice-president of the Polis IPF Patients Society. VM reports personal fees from Boehringer Ingelheim and Roche outside the submitted work; and travel grants from Boehringer Ingelheim and Roche. JTT reports personal lecture fees from Roche and Boehringer Ingelheim; and advisory board participation for Boehringer Ingelheim. MV reports personal fees or honoraria for lectures or presentations from Boehringer Ingelheim and Roche; support for conference attendance from Boehringer Ingelheim and Roche; advisory board participation for Boehringer Ingelheim; is the president of the Czech Pneumologic and Phtisiologic Society; and is the head of the EMPIRE registry. MŠ, MH, MS and SL have nothing to disclose.